Optimal and Ensure Trials - Based Combined Cost-Effectiveness Analysis of Erlotinib Versus Chemotherapy for the First- Line Treatment of Asian Patients with Nonsquamous Non– Small-Cell Lung Cancer
Nov 1, 2016, 00:00
10.1016/j.jval.2016.08.274
https://www.valueinhealthjournal.com/article/S1098-3015(16)30854-3/fulltext
Title :
Optimal and Ensure Trials - Based Combined Cost-Effectiveness Analysis of Erlotinib Versus Chemotherapy for the First- Line Treatment of Asian Patients with Nonsquamous Non– Small-Cell Lung Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30854-3&doi=10.1016/j.jval.2016.08.274
First page :
A888
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2735